Information session on the pilot for expert panels' advice for orphan medical devices, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 14:00 (CEST) to 23 September 2024, 16:30 (CEST)

Submitted by Anonymous (not verified) on 27 November 2024 - 15:11

Information session on the pilot for expert panels' advice for orphan medical devices, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 14:00 (CEST) to 23 September 2024, 16:30 (CEST)

Clinical Trials Information System (CTIS): Walk-in clinic - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 16:00 (CET) to 20 November 2024, 17:00 (CET)

Submitted by Anonymous (not verified) on 27 November 2024 - 15:06

Clinical Trials Information System (CTIS): Walk-in clinic - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 16:00 (CET) to 20 November 2024, 17:00 (CET)

Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 27 November 2024 - 15:05

Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Date of authorisation: 19/12/2014, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 27 November 2024 - 13:48

Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Date of authorisation: 19/12/2014, Revision: 12, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More